Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

October 24, 2024 10:50 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") and low-dose interferon therapeutics, shared promising clinical progress of VELDONA® and its growth opportunities alongside upcoming milestones in the Water Tower Research ("WTR") Small-Cap Spotlight podcast, signaling strong potential for both human and animal health markets. WTR has...

Read more

Positive Partial 12-Week Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study

October 24, 2024 9:10 AM

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received partial 12-week (final) blood sugar results from the recently completed animal study WEIGHT-A24-1 (the "Study").Blood Sugar Levels (mmol/L)DehydraTECH GroupsDay 7 BaselineDay 28% Change to Day 28Day 56% Change to Day 56Day 84% Change to Day 84A: CBD127.426.2-4.31%26.9-1.90%27.71.09%B:...

Read more

Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

October 24, 2024 8:30 AM

Ludwig Enterprises, Inc, (OTC PINK:LUDG), a leading USA-based biotechnology company, has filed a provisional patent for its breakthrough cancer detection method titled "mRNAs Differentially Expressed in Cancer." The company's latest innovation, which analyzes a six-mRNA gene combination, has demonstrated a significant increase in sensitivity and specificity for breast cancer detection, compared to previous methods. "We were already doing well,...

Read more

CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push

October 24, 2024 8:00 AM

The U.S. is on the verge of a historic shift. With the Biden administration, led by Vice President Kamala Harris, taking bold steps toward federal marijuana legalization, the opportunities for companies in the cannabis and CBD sectors are poised to skyrocket. For CBD Life Sciences Inc. (CBDL), this is more than just a legislative breakthrough, it is a once-in-a-generation chance to capitalize on a booming market and become a dominant force in...

Read more

Compassion Center Joins Coalition for Patient Rights in Urging DEA Hearing to Deschedule Cannabis, Protect Patient Rights and Take Action at Dec.2nd Deschedule Not Reschedule Rally

October 24, 2024 8:00 AM

Compassion Center, a pioneering leader in integrative and alternative healthcare, mental health and medical cannabis advocacy, announces its solidarity with the Coalition For Patient Rights (CPR), United Empowerment Party and Nicholas Barreto, Atlas Alchemy LLC and The Key, Dopeass Glass and Jack Long, Elune Solutions,Farmer Tom Organics and Farmer Tom Lauerman, Medical Cannalyst Consulting Group LLC (MCCG), Integrative Providers Association...

Read more

CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia

October 24, 2024 8:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved the Company's Clinical Trial Application (CTA) to proceed with a phase 1/2 study of CID-103 in adults patients with chronic Immune Thrombocytopenia...

Read more

Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention

October 24, 2024 8:00 AM

Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease hosted a physician-focused webinar entitled, "New Approaches to Treating Peripheral Artery Disease (PAD) Below-the-Knee (BTK) and Promising New BTK Data." A recording of the webinar may be accessed at...

Read more

Compassion Center and SIDHE Calls for Urgent Action on Misleading and Dangerous Psychedelic Products Flooding the Market

October 24, 2024 8:00 AM

The psychedelic space is on the verge of a breakthrough-but also faces a potentially dangerous crisis. As interest in psychedelics grows, so does the number of profiteers capitalizing on the legal gray areas of the movement. Compassion Center, and the Syndicated Investigators Delving into Hallucinogens Ethically (SIDHE), a leading research institute under the Center for Incubations and Findings Research (CIFR), have uncovered alarming trends...

Read more

Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform

October 24, 2024 6:30 AM

Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the release of the Ear Cytology Quick Scan protocol, a new feature available on the TRUVIEW microscope equipped with the TRUprep™ automated slide preparation system. This innovative feature streamlines the slide preparation and scanning of ear...

Read more

AlzeCure to Present at the International Partnering Conference Bioscience 2024 on November 7

October 24, 2024 4:15 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company's co-founder and Head of Discovery and Research, Dr. Pontus Forsell, will present at the 12th annual Bioscience conference, held at Life City in Stockholm, Sweden.Alzecure Pharma, as a company...

Read more

Interim Report January-September 2024

October 24, 2024 2:00 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Third quarter 2024 (July 1 - September 30)• Net sales amounted to SEK 198.5 million (146.6), corresponding to growth of 35 percent in SEK and 41 percent in local currencies.• Organic growth accounted for 41 percent, and currency effects for -6 percent.• The Business areas Thoracic and Abdominal delivered underlying organic growth adjusted for currency effects: Thoracic disposables 54 percent and...

Read more

Ascelia Pharma Presents Late-Breaking Abstract on SPARKLE Data at the American Society of Nephrology Kidney Week Congress 2024

October 24, 2024 2:00 AM

Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that its latest scientific abstract, titled "SPARKLE: A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of ACE-MBCA (Orviglance) in Patients with Known or Suspected Focal Liver Lesions and Severe Renal Impairment," has been accepted as part of the...

Read more

Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET

October 23, 2024 7:20 PM

Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, November 7, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its thirdquarter ended September 30, 2024. A question-and-answer session will follow management's...

Read more

Buckeye Medical Technologies Receives Fifth Patent for AnatotempSC Anatomic Dental Implant Healing Abutment Scan Body

October 23, 2024 4:00 PM

YOUNGSTOWN, OH / ACCESSWIRE / October 23, 2024 / Buckeye Medical Technologies Ltd. is proud to announce the approval of its fifth U.S. utility patent for the AnatotempSC anatomic dental implant healing abutment scan body components and system. This groundbreaking product offers a dual-function solution: it serves as both an anatomic dental implant healing abutment that ensures an ideal gingival emergence profile and as a scan body used during...

Read more

CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

October 23, 2024 2:50 PM

HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it has entered into securities purchase agreements with institutional investors for the purchase and sale of 17,647,060 shares of common stock (or common stock...

Read more

ParkerWhite Names Luke Lauer as New Chief Executive Officer

October 23, 2024 2:20 PM

SAN DIEGO, CA / ACCESSWIRE / October 23, 2024 / ParkerWhite, a brand-focused marketing agency specializing in partnering with medical device and healthcare companies to bring life-changing products to market, is proud to announce the appointment of Luke Lauer as its new Chief Executive Officer. Mr. Lauer steps into this leadership role with a proven track record of innovation and growth in the digital marketing sector, aligning with...

Read more

My Quest Story – Martha Baer

October 23, 2024 1:30 PM

NORTHAMPTON, MA / ACCESSWIRE / October 23, 2024 / Quest Diagnostics I have been with Quest Diagnostics since 1993, celebrating my 31 years with the company this past July. My entire career has been in Logistics. I began my career as a courier, working for what then was Nichols Institute. For the next several years, we experienced transitions to Corning Clinical Laboratories and ultimately to Quest Diagnostics.The big change came when Quest...

Read more

Kenneth Petterson Shares Insights on Leadership and Philanthropy in an Exclusive Interview

October 23, 2024 1:30 PM

Kenneth Petterson, the Director of Donor Engagement at the Autism Spectrum Disorder Foundation and a seasoned philanthropist, was featured in an exclusive online interview titled "What Does Success Look Like To You?" Kenneth shared his invaluable experiences and perspectives gained over 30 years in the nonprofit sector, particularly focusing on organizations that support individuals with autism.In the interview, Kenneth reflects on what...

Read more

AGS Health’s Fax Automation Solution Honored by UiPath with Prestigious AI25 Award

October 23, 2024 1:00 PM

AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., has received a UiPath AI25 Award for the company's innovative use of automation and AI to support greater accuracy and efficiency in the intake and management of faxed documents.Despite efforts to eliminate faxing, use of this cumbersome, inefficient, and costly technology by healthcare...

Read more

Global Ocular Immunosuppresents Market Set for Substantial Growth: Expected to Reach USD 12,476.2 Million by 2034 | Future Market Insights, Inc.

October 23, 2024 1:00 PM

The global sales of ocular immunosuppresents are projected to reach USD 4,603.4 million in 2024, with an impressive anticipated growth to USD 12,476.2 million by 2034, according to recent market research. This growth trajectory reflects a robust compound annual growth rate (CAGR) of 10.5% over the forecast period from 2024 to 2034. The revenue generated by ocular immunosuppresents in 2023 was USD 4,215.8 million, highlighting a significant...

Read more